Status:
RECRUITING
Shanghai Clinical Cohort - Adrenal Disease
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Collaborating Sponsors:
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
RenJi Hospital
Conditions:
Adrenal Disease
Eligibility:
All Genders
18-75 years
Brief Summary
As a vital organ responsible for producing life-sustaining hormones, the adrenal gland is associated with a wide range of diseases. These diseases affect multiple systems throughout the body and carry...
Eligibility Criteria
Inclusion
- A signed and dated informed consent form
- Commitment to abide by the study procedures and cooperate with the implementation of the entire study process
- Patients diagnosed with adrenal diseases, including aldosteronism, Cushing's syndrome, pheochromocytoma, adrenocortical carcinoma, and congenital adrenal hyperplasia; regardless of whether they have received adrenal surgery, radiotherapy, and/or medication therapy
- Aged between 18 and 75 years
Exclusion
- Subjects meeting any of the following criteria will be excluded from this study:
- Refuse to sign the informed consent form
- Patients without adrenal diseases
- Have specified diseases or conditions (physical or psychological, identified through physical examination) that warrant exclusion from the study
Key Trial Info
Start Date :
July 25 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT07191951
Start Date
July 25 2025
End Date
December 31 2025
Last Update
November 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jiang yiran
Shanghai, China